Hong Kong - New York City | U.S.A.
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Education • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Food & Beverage • Impact • Insurance (& InsurTech) • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Payments • Robotics • Aerospace (& Defense) • Real Estate (& Construction) • DeepTech • Healthcare (& Wellness) • Investment Management • Life Science • Mobile • Nanotechnology • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
| Stages | Pre-Seed, Seed, Early Stage, Series A, Series B |
| Investing | United States • United Kingdom • Germany • India • France • China • Singapore • Hong Kong • Portugal • Belgium • Ireland • Thailand • Indonesia • Pakistan |
| Investment Range | $100,000 - $2,000,000 |
| Investment Sweet Spot | $1,000,000 |
| Assets Under Management | $1,200,000,000 |
About The Fund
SOSV is a global venture capital firm that invests across multiple stages with a deep focus on deep tech for human and planetary health, aiming for a radically beneficial impact. With headquarters in Princeton, New Jersey, and founded in 1994, SOSV has become a prominent VC, known for its accelerator-based approach. The firm invests in a wide variety of sectors including software, education, biotech, agrotech, fintech, hardware, energy, retail, IoT, cleantech, AI, healthtech, blockchain, food & beverage, impact, and more. Their investment stages include pre-seed, seed, early-stage, Series A, and Series B, with a specialty in supporting pre-seed deep tech companies. SOSV's investment size ranges from a minimum of $100,000 to a maximum of $2,000,000, with a sweet spot around $1,000,000. Its assets under management total approximately $1.2 billion. Through their startup development programs, IndieBio and HAX, SOSV facilitates the growth of deep tech startups in fields such as synthetic biology, therapeutics, food innovation, and material science among others. They provide robust laboratory and office spaces for founders to develop their prototypes and access sophisticated equipment. With over 1,000 co-investors in their network, SOSV actively participates in follow-on funding rounds and propels their deep tech portfolio to raise significant capital post-program. The firm champions diversity among its founders and teams, who represent numerous nationalities and educational backgrounds, with many holding PhDs. SOSV curates events and summits to drive the climate and health tech ecosystems, reinforcing its dedication to human and planetary health throughout the lifetime of its investments.
What they say:
We invest in pre-seed deep tech companies through one of our accelerators. Life sciences (synthetic biology, syn bio, healthcare, climate tech, clean tech, therapeutics, drug, food, cell cultured meats, biomanufacturing, neuroscience, etc.)
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
